Nerve Repair and Regeneration Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Nerve Repair & Regeneration Market: By Surgery (Direct Neuropathy, Nerve Grafting, Stem Cell Therapy, Neuromodulation Surgery), by product (Biomaterials, Neuromodulation Surgery Devices and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Global Nerve Repair and Regeneration Market was valued at $5,928 million in 2021 and is anticipated to grow at $13,939 million till 2028 recording a CAGR of 13.1% during the forecast period 2021-2028.  The number of incidence of peripheral nerve injury cases due to trauma, accidents, or nerve damage cases are increasing day by day leading to increased demand of novel diagnostic and treatment methods. For instance, In Canada and US the primary cause of nerve damage is motor vehicle accidents, annually, 26-46% people in US, 52% in Toronto, 43% in Brazil and 26.9 % in Turkey suffers from nerve damage, Europe accounts for about 300,000 cases of traumatic PNI per annum and in India, trauma is one of the leading causes of death and disability with 400,000 road crashes, 85,000 deaths, and 1.2 million seriously injured cases annually. Global nerve repair & regeneration industry is surging owing to frequent acquisitions, product approval, collaborations, and product launches by the market players. For instance, In November 2017, the Stryker Corporation received humanitarian device exemption approval from the US Food and Drug Administration for its Neuroform Atlas stent system.

Nerve Repair And Regeneration Market

MARKET SUMMARY
-
13.1%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 13.1%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Nerve Repair and Regeneration Market

  • The report on global nerve repair & regeneration market gives historical, current, and future market sizes (US$ Mn) on the basis of product type and region.
  • This report studies global nerve repair & regeneration industry dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • In addition, global nerve repair & regeneration market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
  • Moreover, PBI analyzed global nerve repair & regeneration industry to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
  • Key stakeholders of the global nerve repair & regeneration industry report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global Nerve Repair & Regeneration products.
Market Key Players
  • Stryker Corporation
  • AxoGen, Inc.
  • Integra Life Sciences Holdings Corporation
  • Polyganics BV
Growth

Nerve Repair & Regeneration Market

Nerve Repair & Regeneration Market due to increasing incidence of peripheral nerve injury day by day. Trauma is supposed to be the most frequent cause of nerve damage which increased its demand among the patients for their advanced treatments. Surge in demand for these products among the surgeons and patients are also bolstering the growth of the nerve repair & regeneration industry. Additionally, advancements in the nerve repair and regeneration products are also creating lucrative opportunities for the market players.


North-America Got Significant Share

Nerve Repair & Regeneration Market

Global nerve repair & regeneration market report gives comprehensive outlook on nerve repair & regeneration across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America accounted for larger revenue share in global nerve repair & regeneration industry with significant CAGR due to launch of many nerve repair and regeneration products in US market. Most of the key market players are from US and are continuously adopting strategies to expand their market in different regions across the world. After North America, Europe leads the nerve repair & regeneration industry owing to more cases of nerve damage or injury caused due to trauma or surgery. For instance, Europe accounts for about 300,000 cases of traumatic peripheral nerve injury cases annually. Asia Pacific nerve repair & regeneration industry accounted for significant growth in the forecast period due to their increased rates of trauma and nerve damage cases coupled with road accidents. For instance in India, trauma is one of the leading causes of death and disability with 1.2 million seriously injured cases annually. Along with it technological development and emerging economies will help in the growth of nerve repair & regeneration industry in APAC region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

KEY FEATURES OF THE REPORT

  • The report provides granular level information about the market size, regional market share, historic market (2016 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Key

Key Findings of the Report

Nerve Repair & Regeneration Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Nerve Repair and Regeneration Market Introduction
2.1. Global Nerve Repair and Regeneration Market – Taxonomy
2.2. Global Nerve Repair and Regeneration Market –Definitions
2.2.1. By Surgery
2.2.2. By Product
2.2.3. By Region
3. Global Nerve Repair and Regeneration Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Nerve Repair and Regeneration Market Dynamic Factors – Impact Analysis
3.6. Global Nerve Repair and Regeneration Market – Competition Landscape
4. Global Nerve Repair and Regeneration Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Nerve Repair and Regeneration Market, By Surgery, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
5.1. Direct Neuropathy
5.1.1. Epineural Repair
5.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Perineural Repair
5.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Group Fascicular Repair
5.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.2. Nerve Grafting
5.2.1. Autografts
5.2.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Allografts
5.2.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Xenografts
5.2.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.3. Stem Cell Therapy
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Neuromodulation Surgery
5.4.1. External Neuromodulation Surgery
5.4.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.1.3. Market Opportunity Analysis
5.4.2. Internal Neuromodulation Surgery
5.4.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.2.3. Market Opportunity Analysis
6. Global Nerve Repair and Regeneration Market, By Product, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
6.1. Biomaterials
6.1.1. Nerve Conduits
6.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.1.3. Market Opportunity Analysis
6.1.2. Nerve Protectors
6.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.2.3. Market Opportunity Analysis
6.1.3. Nerve Wraps
6.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3.3. Market Opportunity Analysis
6.1.4. Nerve Connectors
6.1.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.4.3. Market Opportunity Analysis
6.2. Neuromodulation Surgery Devices
6.2.1. External Neuromodulation Surgery
6.2.1.1. Transcutaneous Electrical Nerve Stimulation
6.2.1.1.1.Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.1.1.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.1.1.3.Market Opportunity Analysis
6.2.1.2. Transcranial Magnetic Stimulation
6.2.1.2.1.Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.1.2.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.1.2.3.Market Opportunity Analysis
6.2.2. Internal Neuromodulation Surgery
6.2.2.1. Spinal Cord Stimulation
6.2.2.1.1.Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2.1.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.1.3.Market Opportunity Analysis
6.2.2.2. Deep Brain Stimulation
6.2.2.2.1.Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2.2.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.2.3.Market Opportunity Analysis
6.2.2.3. Sacral Nerve Stimulation
6.2.2.3.1.Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2.3.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.3.3.Market Opportunity Analysis
6.2.2.4. Vagus Nerve Stimulation
6.2.2.4.1.Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2.4.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.4.3.Market Opportunity Analysis
6.2.2.5. Others
6.2.2.5.1.Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2.5.2.Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.2.5.3.Market Opportunity Analysis
7. Global Nerve Repair and Regeneration Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Nerve Repair and Regeneration Market – Opportunity Analysis Index, By Surgery, Product, and Region, 2022 – 2028
8. North America Nerve Repair and Regeneration Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
8.1. Surgery Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Direct Neuropathy
8.1.1.1. Epineural Repair
8.1.1.2. Perineural Repair
8.1.1.3. Group Fascicular Repair
8.1.2. Nerve Grafting
8.1.2.1. Autografts
8.1.2.2. Allografts
8.1.2.3. Xenografts
8.1.3. Stem Cell Therapy
8.1.4. Neuromodulation Surgery
8.1.4.1. External Neuromodulation Surgery
8.1.4.2. Internal Neuromodulation Surgery
8.2. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Biomaterials
8.2.1.1. Nerve Conduits
8.2.1.2. Nerve Protectors
8.2.1.3. Nerve Wraps
8.2.1.4. Nerve Connectors
8.2.2. Neuromodulation Surgery Devices
8.2.2.1. External Neuromodulation Surgery
8.2.2.1.1.   Transcutaneous Electrical Nerve Stimulation
8.2.2.1.2.   Transcranial Magnetic Stimulation
8.2.2.2. Internal Neuromodulation Surgery
8.2.2.2.1.   Spinal Cord Stimulation
8.2.2.2.2.   Deep Brain Stimulation
8.2.2.2.3.   Sacral Nerve Stimulation
8.2.2.2.4.   Vagus Nerve Stimulation
8.2.2.2.5.   Others
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Nerve Repair and Regeneration Market – Opportunity Analysis Index, By Surgery, Product, and Country, 2022 – 2028
8.5. North America Nerve Repair and Regeneration Market Dynamics – Trends
9. Europe Nerve Repair and Regeneration Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
9.1. Surgery Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Direct Neuropathy
9.1.1.1. Epineural Repair
9.1.1.2. Perineural Repair
9.1.1.3. Group Fascicular Repair
9.1.2. Nerve Grafting
9.1.2.1. Autografts
9.1.2.2. Allografts
9.1.2.3. Xenografts
9.1.3. Stem Cell Therapy
9.1.4. Neuromodulation Surgery
9.1.4.1. External Neuromodulation Surgery
9.1.4.2. Internal Neuromodulation Surgery
9.2. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Biomaterials
9.2.1.1. Nerve Conduits
9.2.1.2. Nerve Protectors
9.2.1.3. Nerve Wraps
9.2.1.4. Nerve Connectors
9.2.2. Neuromodulation Surgery Devices
9.2.2.1. External Neuromodulation Surgery
9.2.2.1.1.   Transcutaneous Electrical Nerve Stimulation
9.2.2.1.2.   Transcranial Magnetic Stimulation
9.2.2.2. Internal Neuromodulation Surgery
9.2.2.2.1.   Spinal Cord Stimulation
9.2.2.2.2.   Deep Brain Stimulation
9.2.2.2.3.   Sacral Nerve Stimulation
9.2.2.2.4.   Vagus Nerve Stimulation
9.2.2.2.5.   Others
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Europe Nerve Repair and Regeneration Market – Opportunity Analysis Index, By Surgery, Product, and Country, 2022 – 2028
9.5. Europe Nerve Repair and Regeneration Market Dynamics – Trends
10. Asia-Pacific Nerve Repair and Regeneration Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
10.1. Surgery Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Direct Neuropathy
10.1.1.1. Epineural Repair
10.1.1.2. Perineural Repair
10.1.1.3. Group Fascicular Repair
10.1.2. Nerve Grafting
10.1.2.1. Autografts
10.1.2.2. Allografts
10.1.2.3. Xenografts
10.1.3. Stem Cell Therapy
10.1.4. Neuromodulation Surgery
10.1.4.1. External Neuromodulation Surgery
10.1.4.2. Internal Neuromodulation Surgery
10.2. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Biomaterials
10.2.1.1. Nerve Conduits
10.2.1.2. Nerve Protectors
10.2.1.3. Nerve Wraps
10.2.1.4. Nerve Connectors
10.2.2. Neuromodulation Surgery Devices
10.2.2.1. External Neuromodulation Surgery
10.2.2.1.1.Transcutaneous Electrical Nerve Stimulation
10.2.2.1.2.Transcranial Magnetic Stimulation
10.2.2.2. Internal Neuromodulation Surgery
10.2.2.2.1.Spinal Cord Stimulation
10.2.2.2.2.Deep Brain Stimulation
10.2.2.2.3. Sacral Nerve Stimulation
10.2.2.2.4.Vagus Nerve Stimulation
10.2.2.2.5.  Others
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Nerve Repair and Regeneration Market – Opportunity Analysis Index, By Surgery, Product, and Country, 2022 – 2028
10.5. Asia-Pacific Nerve Repair and Regeneration Market Dynamics – Trends
11. Latin America Nerve Repair and Regeneration Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
11.1. Surgery Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Direct Neuropathy
11.1.1.1. Epineural Repair
11.1.1.2. Perineural Repair
11.1.1.3. Group Fascicular Repair
11.1.2. Nerve Grafting
11.1.2.1. Autografts
11.1.2.2. Allografts
11.1.2.3. Xenografts
11.1.3. Stem Cell Therapy
11.1.4. Neuromodulation Surgery
11.1.4.1. External Neuromodulation Surgery
11.1.4.2. Internal Neuromodulation Surgery
11.2. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Biomaterials
11.2.1.1. Nerve Conduits
11.2.1.2. Nerve Protectors
11.2.1.3. Nerve Wraps
11.2.1.4. Nerve Connectors
11.2.2. Neuromodulation Surgery Devices
11.2.2.1. External Neuromodulation Surgery
11.2.2.1.1.Transcutaneous Electrical Nerve Stimulation
11.2.2.1.2.  Transcranial Magnetic Stimulation
11.2.2.2. Internal Neuromodulation Surgery
11.2.2.2.1.Spinal Cord Stimulation
11.2.2.2.2. Deep Brain Stimulation
11.2.2.2.3.  Sacral Nerve Stimulation
11.2.2.2.4. Vagus Nerve Stimulation
11.2.2.2.5.   Others
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Nerve Repair and Regeneration Market – Opportunity Analysis Index, By Surgery, Product, and Country, 2022 – 2028
11.5. Latin America Nerve Repair and Regeneration Market Dynamics – Trends
12. Middle East and Africa Nerve Repair and Regeneration Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
12.1. Surgery Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Direct Neuropathy
12.1.1.1. Epineural Repair
12.1.1.2. Perineural Repair
12.1.1.3. Group Fascicular Repair
12.1.2. Nerve Grafting
12.1.2.1. Autografts
12.1.2.2. Allografts
12.1.2.3. Xenografts
12.1.3. Stem Cell Therapy
12.1.4. Neuromodulation Surgery
12.1.4.1. External Neuromodulation Surgery
12.1.4.2. Internal Neuromodulation Surgery
12.2. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Biomaterials
12.2.1.1. Nerve Conduits
12.2.1.2. Nerve Protectors
12.2.1.3. Nerve Wraps
12.2.1.4. Nerve Connectors
12.2.2. Neuromodulation Surgery Devices
12.2.2.1. External Neuromodulation Surgery
12.2.2.1.1.   Transcutaneous Electrical Nerve Stimulation
12.2.2.1.2.    Transcranial Magnetic Stimulation
12.2.2.2. Internal Neuromodulation Surgery
12.2.2.2.1.   Spinal Cord Stimulation
12.2.2.2.2.   Deep Brain Stimulation
12.2.2.2.3.   Sacral Nerve Stimulation
12.2.2.2.4.  Vagus Nerve Stimulation
12.2.2.2.5.  Others
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Nerve Repair and Regeneration Market – Opportunity Analysis Index, By Surgery, Product, and Country, 2022 – 2028
12.5. MEA Nerve Repair and Regeneration Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Surgery Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. GiMer Medical (Taiwan)
13.2.2. Medtronic PLC (Ireland)
13.2.3. Abbott Laboratories (US)
13.2.4. Collagen Matrix (US)
13.2.5. NeuroSigma (US)
13.2.6. Boston Scientific Corporation (US)
13.2.7. Intergra LifeSciences (US)
13.2.8. Nerve Corp (US)
13.2.9. NeuroPace (US)
13.2.10. AxoGen (US)
13.2.11. KeriMedical (Switzerland)
13.2.12. Polyganics (Netherlands)
13.2.13. Synapse Biomedical (US)
13.2.14. BioWave Corporation (US)
13.2.15. tVNS Technologies GmbH (Germany)
13.2.16. Soterix Medical (US)
14. Research Methodology
15. Key Assumptions and Acronyms

Report

Company Profile

  • GiMer Medical (Taiwan)
  • Medtronic PLC (Ireland)
  • Abbott Laboratories (US)
  • Collagen Matrix (US)
  • NeuroSigma (US)
  • Boston Scientific Corporation (US)
  • Intergra LifeSciences (US)
  • Nerve Corp (US)
  • NeuroPace (US)
  • AxoGen (US)
  • KeriMedical (Switzerland)
  • Polyganics (Netherlands)
  • Synapse Biomedical (US)
  • BioWave Corporation (US)
  • tVNS Technologies GmbH (Germany)
  • Soterix Medical (US)

Description

Global Nerve Repair and Regeneration Market was valued at $5,928 million in 2021 and is anticipated to grow at $13,939 million till 2028 recording a CAGR of 13.1% during the forecast period 2021-2028.  The number of incidence of peripheral nerve injury cases due to trauma, accidents, or nerve damage cases are increasing day by day leading to increased demand of novel diagnostic and treatment methods. For instance, In Canada and US the primary cause of nerve damage is motor vehicle accidents, annually, 26-46% people in US, 52% in Toronto, 43% in Brazil and 26.9 % in Turkey suffers from nerve damage, Europe accounts for about 300,000 cases of traumatic PNI per annum and in India, trauma is one of the leading causes of death and disability with 400,000 road crashes, 85,000 deaths, and 1.2 million seriously injured cases annually. Global nerve repair & regeneration industry is surging owing to frequent acquisitions, product approval, collaborations, and product launches by the market players. For instance, In November 2017, the Stryker Corporation received humanitarian device exemption approval from the US Food and Drug Administration for its Neuroform Atlas stent system.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX